Principal Investigator(s):John Warin Ward
Objective:Evaluate and compare the safety and immunogenicity of two doses of candidate HIV-1 clade A DNA vaccine and a candidate HIV-1 clade A MVA vaccine.
Prevention Option(s):HIV Vaccine
Arms and Assigned Interventions
DescriptionTwo doses of candidate HIV-1 clade A DNA vaccine versus a placebo followed by a candidate HIV-1 clade A MVA vaccine or placebo.
Mode of DeliveryIntramuscular
Official Code: IAVI 006
Trial Sponsors: IAVI, John Warin Ward, Medical Research Council (MRC), St. Mary's Hospital
Age range: ↔ any